Part 3

ISHD Hemodialysis University™
Hyderabad, India.  March 1st & 2nd 2014
     HDCN free zone registration is required.
PART THREE. Convective Therapies and What RRT for AKI?
Convective Therapies in Chronic HD Patients: Basics and Beyond
Bernard Canaud, MD
Questions and Answers
Does RRT modality choice matter for the patient with AKI ?
Andrew Davenport, MD
Questions and Answers

Bernard Canaud, MD
Professor of Nephrology
Montpellier University School of Medicine
Lapeyronie Hospital
Montpellier, France

Andrew Davenport, MD
Director of Dialysis Research
UCL Centre for Nephrology
Royal Free Hospital
University College London Medical School
This educational activity is an audio recording with accompanying slides of a live presentation held on March 1st and 2nd, 2014, in Hyderabad, India.

Web archiving was made possible thanks to a generous unrestricted educational grant from Baxter Healthcare.

Continuing medical education credit is not available for this on-line archive. To view this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from is useful but not necessary to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the slide handouts.

Program Overview:

Target Audience:
This program is intended for practicing Nephrologists, nephrology fellows, dialysis technologists, interventional nephrologists, vascular access surgeons, and health professionals involved in dialysis programs.
Disclosure Policy:
It is the policy of the ISHD and HDCN that speakers with potential conflicts of interest disclose these at the time of presentation.

Off-label/lnvestigational Use:
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be "off-label" use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.

The policy statements of HDCN are listed on this page.